Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Leonor A Stephens
Observed names:
Leonor A. Stephens,
Leonor Ano Stephens,
Leonor Stephens
Institution:
University of Chicago Medical Center
Observed institutions:
University of Chicago,
University of Chicago Medical Center
OpenAlex ID:
A5084491366
Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma
2020
·
Jagoda K. Jasielec
, Tadeusz Kubicki
, et al.
·
Blood
·
74
PDF
Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma
2019
·
Andrzej J. Jakubowiak
, Jagoda K. Jasielec
, et al.
·
British Journal of Haematology
·
69
PDF
Final Results of a Phase 2 Trial of Extended Treatment (tx) with Carfilzomib (CFZ), Lenalidomide (LEN), and Dexamethasone (KRd) Plus Autologous Stem Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (NDMM)
2016
·
Todd Zimmerman
, Noopur S. Raje
, et al.
·
Blood
·
45
Final Results of Phase 1 MMRC Trial of Selinexor, Carfilzomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma (RRMM)
2016
·
Andrzej Jakubowiak
, Jagoda Jasielec
, et al.
·
Blood
·
13
High Rate of Sustained Minimal Residual Disease Negativity Predicts Prolonged Survival for the Overall Patient Population in the Phase 2 KRd Plus Autologous Stem Cell Transplantation MMRC Trial
2017
·
Andrzej Jakubowiak
, Noopur Raje
, et al.
·
Blood
·
10
Phase 1/2 study of carfilzomib, pomalidomide, and dexamethasone (KPd) in patients (Pts) with relapsed/refractory multiple myeloma (RRMM): A Multiple Myeloma Research Consortium multicenter study.
2016
·
Cara Ann Rosenbaum
, Leonor Ano Stephens
, et al.
·
Journal of Clinical Oncology
·
8
Phase 1 MMRC Trial of Selinexor, Carfilzomib (CFZ), and Dexamethasone (DEX) in Relapsed and Relapsed/Refractory Multiple Myeloma (RRMM)
2015
·
Andrzej Jakubowiak
, Jagoda Jasielec
, et al.
·
Blood
·
7
Carfilzomib (CFZ, Kyprolis®), Lenalidomide (LEN, Revlimid®), and Dexamethasone (DEX) (KRd) Combined with Autologous Stem Cell Transplant (ASCT) Shows Improved Efficacy Compared with Krd without ASCT in Newly Diagnosed Multiple Myeloma (NDMM)
2016
·
Todd M. Zimmerman
, Kent Griffith
, et al.
·
Transplantation and Cellular Therapy
·
1
Using Novel Genetically Engineered Mouse Models of Soft Tissue Sarcoma to Interrogate the Contribution of Cell of Origin and Tissue Injury to Sarcoma Development
2015
·
Leonor A Stephens
·
DukeSpace (Duke University)
Show more works
View as search
Works count:
9
Citation count:
227
H-index:
7
I10-index:
5
Year
Topic
Type
